On September 12, 2024, Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) announced the appointment of Harold Wolkin as an independent director on its Board of Directors. With over 30 years of experience in the finance sector, Mr. Wolkin has held significant roles in investment banking at firms such as BMO Capital Markets and Dundee Capital Markets. His expertise will be valuable in guiding Flora’s financial strategy and governance as the company expands its global operations.
Mr. Wolkin also serves on the boards of several publicly listed companies and is actively involved in the financial community. He holds a Bachelor of Arts in Economics from York University and a Master of Arts in Economics and Finance from the University of Toronto. In addition, he is a member of the Chartered Financial Institute and has been a Chartered Financial Analyst (CFA) since 1980.
Concurrently with Mr. Wolkin’s appointment, Mr. Clifford Starke has been appointed as Chairman of the Board of Directors. Mr. Starke currently serves as the Chief Executive Officer of Flora Growth Corp.
Clifford Starke, Chairman, and CEO of Flora Growth Corp. expressed his enthusiasm for Mr. Wolkin’s appointment, citing his financial market knowledge and strategic insights as crucial assets for the company’s global growth. On the other hand, Mr. Wolkin expressed his honor to join Flora at a pivotal time and is enthusiastic about contributing to the company’s success.
Flora Growth Corp. is a consumer-packaged goods leader and pharmaceutical distributor with a global presence. The company is focused on enhancing shareholder value, exploring strategic growth avenues, and maintaining the highest standards of corporate governance.
This press release contains forward-looking statements that involve uncertainties and risks. Factors such as Harold Wolkin’s guidance on Flora’s financial strategy, the company’s global expansion efforts, and the complexities of the international cannabis market may impact actual results. The company disclaims any obligation to publicly update or revise forward-looking statements. To view the original press release, please visit the source link provided.
